Ignite Creation Date:
2024-05-05 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00525447
Status:
COMPLETED
Last Update Posted:
2014-10-09
First Post:
2007-08-31
Brief Title:
Study of SGN-40 Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Myeloma |
Keywords:
| Name | View |
|---|---|
| Antibody-Dependent Cell Cytotoxicity | View |
| Antigens CD40 | View |
| Antibodies Monoclonal | View |
| Combined Modality Therapy | View |
| Multiple Myeloma | View |
| Blood Coagulation Disorders | View |
| Hematologic Diseases | View |
| Hemorrhagic Disorders | View |
| Hemostatic Disorders | View |
| Immunoproliferative Disorders | View |
| Lymphoproliferative Disorders | View |
| Paraproteinemias | View |
| Vascular Diseases | View |